Back to search
FDAFDA · Food and drugs·Recall number D-0340-2021

Betamethasone Dipropionate Ointment USP, 0.05% (Augmented), packaged in 15 grams tubes, Manufactured by: Teligent Pharma, Inc. Buena, New Jersey 08310, Distributed by: McKesson Corporation dba Sky Packaging 4971 Southbridge Blvd., Suite 101 Memphis, TN 38141, NDC 63739-996-15

Published May 5, 2021 · Recall initiated: February 2, 2021

Summary

FDA records drug Class III recall D-0340-2021, published May 5, 2021 and initiated February 2, 2021. Recalling firm: Teligent Pharma, Inc.; Status: Terminated; Reported quantity: N/A; Lot: Lot #: 15644, Exp 5/2022. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/ Degradation Specifications - OOS for know impurity Betamethasone 17- propionate.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Teligent Pharma, Inc.
Distributor
USA Nationwide
Lot
Lot #: 15644, Exp 5/2022
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Betamethasone Dipropionate Ointment USP, 0.05% (Augmented), packaged in 15 grams tubes, Manufactured by: Teligent Pharma, Inc. Buena, New Jersey 08310, Distributed by: McKesson Corporation dba Sky Packaging 4971 Southbridge Blvd., Suite 101 Memphis, TN 38141, NDC 63739-996-15 recalled?

Yes. FDA published recall D-0340-2021 on May 5, 2021. Reported hazard: Failed Impurities/ Degradation Specifications - OOS for know impurity Betamethasone 17- propionate.

What should I do if I have this product?

Voluntary: Firm initiated · Letter